Literature DB >> 7589894

Changes in the expression of intermediate filaments and desmoplakins during development of human notochord.

E Lehtonen1, V Stefanovic, M Saraga-Babic.   

Abstract

Indirect immunofluorescence was used to study the expression of desmosomal and intermediate filament (IF) proteins in the human notochord between the 4th and 12th weeks of embryonic development. Towards the end of this period, the development of the notochord is characterized by its gradual physiological atrophy and disappearance inside the vertebral bodies. In all of our embryos, the notochord cells expressed cytokeratin and vimentin but not desmin, neurofilament protein or glial fibrillary acidic protein. Throughout the stages studied, the expression of cytokeratin was strong. Vimentin expression, on the other hand, changed during the stages studied. In our youngest embryos, vimentin could be detected only in the peripheral cells of the notochord. During development, a distinct increase occurred in vimentin expression, and in the oldest embryos, all notochord cells showed bright vimentin-specific fluorescence. Simultaneously with this modification, a change occurred in the expression of desmosomal proteins: The notochord cells expressed desmoplakins abundantly during early stages, but weakly or not at all during later stages. Correspondingly, electron microscopy of the same stages showed a striking decrease in the number of desmosomes between notochord cells. Our results confirm that, during early development, the notochord displays features specific for epithelial cells. This accords with the view that notochord is of epithelial origin. The modifications observed in the expression of IF and desmosomal proteins were temporally correlated with developmentally regulated atrophy of the notochord. The programmed regression of the notochord cells is thus associated with a switch from a predominantly epithelial phenotype to a more mesenchymal one.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7589894     DOI: 10.1046/j.1432-0436.1995.5910043.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  7 in total

Review 1.  The role of extracellular matrix elasticity and composition in regulating the nucleus pulposus cell phenotype in the intervertebral disc: a narrative review.

Authors:  Priscilla Y Hwang; Jun Chen; Liufang Jing; Brenton D Hoffman; Lori A Setton
Journal:  J Biomech Eng       Date:  2014-02       Impact factor: 2.097

2.  Differential expression level of cytokeratin 8 in cells of the bovine nucleus pulposus complicates the search for specific intervertebral disc cell markers.

Authors:  Audrey Gilson; Mathias Dreger; Jill Pg Urban
Journal:  Arthritis Res Ther       Date:  2010-02-12       Impact factor: 5.156

3.  Expression of intermediate filaments, EGF and TGF-alpha in early human kidney development.

Authors:  Dominko Carev; Marijan Saraga; Mirna Saraga-Babic
Journal:  J Mol Histol       Date:  2007-12-15       Impact factor: 2.611

4.  Extracellular matrix ligand and stiffness modulate immature nucleus pulposus cell-cell interactions.

Authors:  Christopher L Gilchrist; Eric M Darling; Jun Chen; Lori A Setton
Journal:  PLoS One       Date:  2011-11-07       Impact factor: 3.240

5.  Immunohistochemical study of cytoskeletal and extracellular matrix components in the notochord and notochordal sheath of amphioxus.

Authors:  Ivana Bocina; Mirna Saraga-Babić
Journal:  Int J Biol Sci       Date:  2006-04-10       Impact factor: 6.580

6.  Integrity of the LXXLL motif in Stat6 is required for the inhibition of breast cancer cell growth and enhancement of differentiation in the context of progesterone.

Authors:  Min Wei; Qi He; Zhongyin Yang; Zhiwei Wang; Qing Zhang; Bingya Liu; Qinlong Gu; Liping Su; Yingyan Yu; Zhenggang Zhu; Guofeng Zhang
Journal:  BMC Cancer       Date:  2014-01-08       Impact factor: 4.430

7.  Gene expression profile and bioinformatics analysis revealed key molecular characteristics of chordoma-before and after TNF- a treatment.

Authors:  Guoyong Xu; Chong Liu; Tuo Liang; Zide Zhang; Jie Jiang; Jiarui Chen; Jiang Xue; Haopeng Zeng; Zhaojun Lu; Xinli Zhan
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.